Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Venous injection of secnidazole

A technology of secnidazole and injection, applied in the field of intravenous injection of secnidazole, can solve the problem of no injection production and marketing, etc.

Inactive Publication Date: 2005-10-12
湖南医药工业研究所有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This variety is mainly used clinically for amoebiasis, giardiasis, urogenital trichomoniasis, and bacterial vaginosis. It has been sold in tablets, capsules, and suspensions abroad, with a specification of 250 mg / kg. Tablets, 500mg / tablet and 750mg / tablet, many manufacturers in China are developing tablets and capsules of this variety, but none of these injections are produced and marketed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] Take 2.5g of secnidazole, add about 700ml of water for injection (or isotonic solution), stir to dissolve, add water for injection (or isotonic solution) to 900ml, adjust the pH to 5.5~6.5, stir evenly, filter, and remove from the container Add water for injection (or isotonic solution) to 1000ml, fine filter, check the content of intermediate products, potting (50ml / bottle, 100ml / bottle, 250ml / bottle, 500ml / bottle), sterilize at 115°C for 30 minutes, clarity Check, pack, and serve. The test results are shown in Table 1.

[0016] name

[0017] Grain

Embodiment 2

[0019] Take about 700ml of water for injection, add 250g of secnidazole, 50g of 2-hydroxypropyl-β-cyclodextrin, 100g of mannitol, stir to dissolve, add water for injection to 900ml, adjust the pH to 5.5-6.5, stir well, filter, and Add water for injection to the container to 1000ml, fine filter, check the content of the intermediate product, pack into 2ml / bottle, and freeze-dry.

[0020] name

Embodiment 3

[0022] Take about 700ml of water for injection, add 125g of secnidazole, 100g of β-cyclodextrin, and 150g of hydroxypropyl cellulose sodium, stir to dissolve, add water for injection to 900ml, adjust the pH to 5.5-6.5, stir well, filter, and remove from the container Add water for injection to 1000ml, fine filter, check the content of the intermediate product, pack into 2ml / bottle, and freeze-dry to obtain.

[0023] name

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An intravenous injection of secindazole is prepared from the secnidazole as active component and the pharmacologically acceptable carrier. Its advantage is quickly taking its high curative effect.

Description

Technical field: [0001] The present invention relates to secnidazole intravenous injection. technical background: [0002] Secnidazole (Secnidazale) belongs to 5-nitroimidazole drugs and metronidazole, tinidazole have the same anti-anaerobic spectrum and anti-anaerobic activity, in the treatment of amoebic protozoa, giardiasis, trichomonas More pronounced features are seen with urogenital disease and bacterial infections of the genitourinary tract. This variety is mainly used clinically for amoebiasis, giardiasis, urogenital trichomoniasis, and bacterial vaginosis. It has been sold in tablets, capsules, and suspensions abroad, with a specification of 250 mg / kg. Tablets, 500mg / tablet and 750mg / tablet, many domestic manufacturers are developing tablets and capsules of this variety, but no injections of this kind are produced and marketed. [0003] In clinical application, injections can directly enter human blood, and the effect is quick and obvious after administration. The...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K31/4164A61P31/10A61P33/02
Inventor 李梅莲陈海波魏云钟硕宇肖方青马宁
Owner 湖南医药工业研究所有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com